US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
CA2479751C
(en)
|
2002-03-20 |
2008-06-03 |
Trent Poole |
Inhalation apparatus
|
US7709639B2
(en)
|
2004-08-20 |
2010-05-04 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
ES2543007T3
(es)
|
2004-08-23 |
2015-08-13 |
Mannkind Corporation |
Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos
|
WO2007033316A2
(en)
|
2005-09-14 |
2007-03-22 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
EP1984049A1
(en)
|
2006-01-19 |
2008-10-29 |
Optinose AS |
Nasal administration
|
EP1986679B1
(en)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
US8614236B2
(en)
*
|
2006-12-12 |
2013-12-24 |
University Of Washington |
Methods of treating pulmonary disease using acetazolamide and structurally related derivatives
|
GB2448183A
(en)
|
2007-04-05 |
2008-10-08 |
Optinose As |
Nasal powder delivery device
|
US8865692B2
(en)
*
|
2007-11-13 |
2014-10-21 |
Meritage Pharma, Inc |
Compositions for the treatment of gastrointestinal inflammation
|
US20100216754A1
(en)
*
|
2007-11-13 |
2010-08-26 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
SI3354276T1
(sl)
|
2007-11-13 |
2020-09-30 |
Meritage Pharma, Inc. |
Sestavki za zdravljenje gastrointestinalnega vnetja
|
DK2230934T3
(da)
|
2007-12-14 |
2012-11-26 |
Aerodesigns Inc |
Afgivelse af aerosoliserbare næringsmiddelprodukter
|
WO2009139506A1
(ja)
*
|
2008-05-15 |
2009-11-19 |
Aspion株式会社 |
異なる物性の薬物の一剤形化
|
TWI611818B
(zh)
|
2008-06-13 |
2018-01-21 |
曼凱公司 |
用於藥物傳輸之乾粉吸入器及系統
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CN103751892B
(zh)
|
2008-06-20 |
2017-03-01 |
曼金德公司 |
用于对吸入工作进行实时描绘的交互式设备和方法
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
EP2676695A3
(en)
|
2009-03-11 |
2017-03-01 |
MannKind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
EP3552603A1
(en)
*
|
2009-03-18 |
2019-10-16 |
Incarda Therapeutics, Inc. |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
MY186975A
(en)
|
2009-06-12 |
2021-08-26 |
Mannkind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
RU2445119C2
(ru)
*
|
2010-05-25 |
2012-03-20 |
Сергей Викторович Чепур |
Фармацевтическая композиция и способ ее ингаляционного введения
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
EP4008326A1
(en)
|
2010-09-29 |
2022-06-08 |
Pulmatrix Operating Company, Inc. |
Monovalent metal cation dry powders for inhalation
|
GB2488992A
(en)
*
|
2011-03-10 |
2012-09-19 |
Advanced Ophthalmic Pharma Ltd |
Medicament dispenser
|
DK2694402T3
(en)
|
2011-04-01 |
2017-07-03 |
Mannkind Corp |
BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
|
BR112013027391A2
(pt)
*
|
2011-05-03 |
2017-01-17 |
Chiesi Farmaceutic S P A |
formulação farmacêutica, frasco e kit
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
BR112014009686A2
(pt)
|
2011-10-24 |
2018-08-07 |
Mannkind Corp |
composição analgésica inalável, pó seco e método para tratar dor
|
ES2624294T3
(es)
|
2012-07-12 |
2017-07-13 |
Mannkind Corporation |
Sistemas de suministro de fármacos en polvo seco
|
JP6197515B2
(ja)
*
|
2012-10-19 |
2017-09-20 |
大正製薬株式会社 |
医薬組成物
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
MX2015012931A
(es)
*
|
2013-03-13 |
2016-07-20 |
Forest Lab Holdings Ltd |
Composiciones farmaceuticas micronizadas.
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
US11554229B2
(en)
|
2013-03-26 |
2023-01-17 |
OptiNose Inc. |
Nasal administration
|
ITMI20130571A1
(it)
*
|
2013-04-10 |
2014-10-11 |
Zambon Spa |
Composizione farmaceutica contenente budesonide e formoterolo
|
ITMI20130572A1
(it)
*
|
2013-04-10 |
2014-10-11 |
Eratech Srl |
Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione
|
EP3607941A1
(en)
|
2013-04-30 |
2020-02-12 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
WO2016004409A1
(en)
*
|
2014-07-03 |
2016-01-07 |
Luxena Pharmaceuticals, Inc. |
Novel aerosol formulations of ondansetron and uses thereof
|
CN104274426A
(zh)
|
2013-07-03 |
2015-01-14 |
陆克塞纳医药公司 |
昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
|
KR102321339B1
(ko)
|
2013-07-18 |
2021-11-02 |
맨카인드 코포레이션 |
열-안정성 건조 분말 약제학적 조성물 및 방법
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
RU2539374C1
(ru)
*
|
2013-11-29 |
2015-01-20 |
Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) |
Высокодисперсная комбинированная фармацевтическая композиция беклометазона и сальбутамола с бета-глицином и способ ее получения
|
GB201321712D0
(en)
*
|
2013-12-09 |
2014-01-22 |
Pharmachemie Bv |
Dry Powder Inhaler
|
CN112656780A
(zh)
|
2014-02-20 |
2021-04-16 |
奥迪托皮克股份有限公司 |
用于吸入的干粉制剂
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
WO2015187356A1
(en)
*
|
2014-06-04 |
2015-12-10 |
Quick Joshua Ryan |
System and method for delivering an inhalable sugar formulation
|
RS58897B1
(sr)
|
2014-09-15 |
2019-08-30 |
Verona Pharma Plc |
Tečna inhalaciona formulacija koja sadrži rpl554
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
MY191712A
(en)
*
|
2014-10-08 |
2022-07-09 |
Zambon Spa |
Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
|
CA2963445C
(en)
*
|
2014-10-08 |
2023-07-18 |
Zambon S.P.A. |
Pharmaceutical composition containing budesonide and formoterol
|
DK3212212T3
(da)
|
2014-10-31 |
2020-12-21 |
Univ Monash |
Pulverformulering
|
JP6908523B2
(ja)
*
|
2015-08-05 |
2021-07-28 |
第一三共株式会社 |
ネブライザー用組成物
|
CN108348459A
(zh)
*
|
2015-09-09 |
2018-07-31 |
诺华股份有限公司 |
靶向递送喷雾干燥制剂到肺
|
US11844782B2
(en)
*
|
2015-10-20 |
2023-12-19 |
Spepharm Ag |
Aqueous composition comprising dantrolene
|
IL260335B2
(en)
|
2016-02-01 |
2023-10-01 |
Incarda Therapeutics Inc |
Combining electronic monitoring with inhaled pharmacological therapy for the management of cardiac arrhythmia including atrial fibrillation
|
BR112018076215A2
(pt)
*
|
2016-06-30 |
2019-03-26 |
Philip Morris Products S.A. |
partículas e composições de nicotina
|
EP3478265A1
(en)
*
|
2016-06-30 |
2019-05-08 |
Philip Morris Products S.a.s. |
Nicotine particles
|
WO2018071757A1
(en)
|
2016-10-14 |
2018-04-19 |
Pulmatrix Operating Company, Inc. |
Antifungal dry powders
|
WO2018163085A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Philip Morris Products S.A. |
Inhalable nicotine formulations, and methods of making and using thereof
|
CA3060702A1
(en)
|
2017-05-10 |
2018-11-15 |
Incarda Therapeutics, Inc. |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
US11344562B2
(en)
|
2017-08-15 |
2022-05-31 |
Nephron Pharmaceuticals Corporation |
Aqueous nebulization composition
|
JP7493449B2
(ja)
|
2017-09-22 |
2024-05-31 |
ヴェクチュラ インコーポレイテッド |
ステアリン酸マグネシウムを含む乾燥粉末組成物
|
US10786456B2
(en)
|
2017-09-22 |
2020-09-29 |
Otitopic Inc. |
Inhaled aspirin and magnesium to treat inflammation
|
WO2019136308A1
(en)
|
2018-01-05 |
2019-07-11 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
WO2019183470A2
(en)
|
2018-03-22 |
2019-09-26 |
Incarda Therapeutics, Inc. |
A novel method to slow ventricular rate
|
WO2020150460A1
(en)
*
|
2019-01-18 |
2020-07-23 |
Milne Iii Donald A |
Micronized aspirin formulation
|
US11020384B2
(en)
|
2019-08-01 |
2021-06-01 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
RU2730488C1
(ru)
*
|
2019-08-20 |
2020-08-24 |
Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича" (ИБМХ) |
Фармацевтическая композиция на основе глюкокортикостероида будесонида и фосфатидилхолина для сухой ингаляции
|
GB201914532D0
(en)
*
|
2019-10-08 |
2019-11-20 |
Univ Of Huddersfield |
Lactose particles and method of production thereof
|
RU2735502C1
(ru)
*
|
2020-01-09 |
2020-11-03 |
Федеральное государственное бюджетное учреждение науки Удмуртский федеральный исследовательский центр Уральского отделения Российской академии наук |
Аэрозоль для ингаляций при обструктивном бронхите
|
CN111202723A
(zh)
*
|
2020-02-15 |
2020-05-29 |
江苏艾立康药业股份有限公司 |
一种达芦那韦吸入干粉药物组合物及其制备方法
|